Search the LJMU website

Search results filters

1. The welcome rise and worrying fall in covert investigation

   Covert techniques and specialist intelligence never appear to be far from the headlines - so why are they on the decline?

2. Groundhog Day or liberation from daily routine?

   Dr Ruth Odgen from the School of Psychology, a lead investigator on a new study into time under COVID-19 isolation, shares her thoughts with us.

3. International Day of Persons with a Disability - reflections from past students

   The School of Sport and Exercise Sciences has chosen to celebrate International Day of Persons with Disabilities by highlighting the successes of some of our past students.

4. Clearing – How to get a Clearing offer 2026

   Received your results and theyre not what you expected? Changed your mind about your choice of course? Decided you want to live at home or move somewhere else? No matter your reasons, LJMU is here to help you prepare for Clearing 2026.

5. Can I afford to go to university?

   Working out how much you can afford can be difficult. Our Money Advice Team are here to help you look after your wallet and your mental health.

6. Why International relations and politics at LJMU?

   Read Sarah's blog telling you the reasons why she thinks international relations and politics at LJMU is the best!

7. Screen School Facilities: A Student’s Perspective

   Josh writes about the different Screen School facilities available to all of our Film Studies, Media Production, Drama and Journalism and Sports Journalism, as well as Performance and Production students.

8. Clearing next steps

   Got your place at LJMU through clearing? Here is what to do next...

9. A trip to Clairefontaine

   Sam Lee and Henry Ogden, BSc (Hons) Science and Football students, share their experiences of their trip to Clairefontaine, the training base for the French national team.

10. Prescription drugs pregabalin and gabapentin have been reclassified – but it won’t stop problem use

    Prescription drugs pregabalin and gabapentin have been reclassified – but it won’t stop problem use